全球細胞庫外包市場

預計到 2030 年，全球細胞銀行外包市場規模將達到 340 億美元

全球細胞庫外包市場規模預計在2024年達到139億美元，預計2024年至2030年期間的複合年成長率為16.1%，到2030年將達到340億美元。主細胞庫是本報告分析的細分市場之一，預計其複合年成長率為18.5%，到分析期結束時規模將達到197億美元。工作細胞庫細分市場在分析期間的複合年成長率預計為14.8%。

美國市場規模估計為 38 億美元，中國市場預計複合年成長率為 21.7%

預計2024年，美國手機銀行外包市場規模將達38億美元。作為世界第二大經濟體，中國市場規模預計到2030年將達到76億美元，在2024-2030年的分析期間內，複合年成長率將達到21.7%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為11.6%和14.6%。在歐洲，預計德國市場的複合年成長率約為12.9%。

全球細胞庫外包市場－主要趨勢與促進因素摘要

為什麼細胞銀行外包的需求不斷增加？

隨著細胞療法、再生醫學和生物製藥研究的日益普及，細胞庫外包的需求也日益成長。隨著製藥和生物技術公司專注於細胞和基因療法、個人化醫療和疫苗生產的開發，對高品質、保存完好的細胞株的需求也顯著增加。外包細胞庫服務使研究機構和藥物開發公司能夠保存、擴展和管理細胞株，而無需承擔維護昂貴內部基礎設施的負擔。

幹細胞療法、單株抗體和生技藥品臨床試驗的興起進一步推動了細胞庫外包的需求。細胞產品開發的複雜性要求嚴格的品管、遵守良好生產規範 (細胞株，這進一步增加了對可靠、專業的細胞庫服務的需求。

科技進步如何改善細胞庫外包？

冷凍保存、自動化生物處理和品質保證技術的創新正在徹底改變細胞庫的外包流程，提高長期細胞儲存的效率和可靠性。其中最重要的進步之一是先進冷凍保護劑和可控冷凍速率的開發，這提高了儲存細胞的活力和穩定性。這些創新降低了遺傳漂變和細胞劣化的風險，確保了生物樣本能夠長期用於研究和治療應用。

另一項重大突破是將人工智慧和自動化技術融入細胞庫業務。人工智慧預測分析和機器人處理系統正在提高流程一致性，減少人為錯誤，並最佳化儲存條件。此外，區塊鏈技術正在被探索用於安全的資料管理和可追溯性，確保細胞庫記錄的完全透明和合規性。採用雲端基礎的樣本追蹤和數位庫存管理系統進一步提高了業務效率，並允許客戶即時遠端監控和管理其儲存的細胞株。

哪些市場趨勢推動了細胞銀行外包產業的發展？

對再生醫學和細胞療法開發的日益關注是影響細胞庫外包市場的最具影響力的趨勢之一。隨著幹細胞研究在神經退化性疾病、心血管疾病和罕見遺傳疾病治療的應用日益廣泛，對高品質幹細胞庫服務的需求也日益成長。生物製藥公司也越來越依賴外包細胞庫來大規模生產生技藥品，包括單株抗體和重組蛋白。

影響市場成長的另一個關鍵趨勢是監管部門對良好生產規範 (GMP) 和標準化細胞儲存通訊協定的重視。隨著全球監管機構收緊細胞療法生產和儲存的指導方針，外包供應商正在投資更高的生物安全水平、符合 GMP 標準的設施和先進的監控系統，以滿足行業標準。此外，生物技術研究領域的國際合作日益增多，推動了對集中式細胞庫服務的需求，這使得公司能夠跨多個地區獲取高品質的細胞株。隨著基於細胞的研究和治療方法的快速擴展，外包細胞庫已成為許多生命科學公司的策略性必需。

影響細胞銀行外包市場未來發展的關鍵成長動力有哪些？

細胞庫外包市場的成長受到多種因素的推動，包括對細胞療法的需求不斷成長、生物保存技術的進步以及對生物製藥研究的投資不斷增加。主要成長要素之一是細胞和基因療法臨床試驗的擴展，這些試驗需要安全且控制良好的細胞株來進行開發和獲得監管部門的核准。隨著製藥公司和研究機構加快在再生醫學領域的佈局，對可靠的細胞庫合作夥伴的需求也日益成長。

影響市場的另一個關鍵促進因素是個人化醫療和精準治療的日益普及。隨著細胞療法越來越針對特定患者，對客製化細胞庫解決方案的需求也日益成長，包括自體和異體細胞儲存服務。此外，生物製藥公司與受託製造廠商(CDMO) 之間日益增多的合作，使得更具可擴展性和成本效益的外包解決方案成為可能。隨著生命科學產業的持續創新，細胞庫外包預計將在促進治療方法突破、確保樣本長期保存以及支持下一代生物製藥的開發方面發揮關鍵作用。

部分

類型（主細胞庫、工作細胞庫、病毒細胞庫）；細胞類型（幹細胞、非幹細胞）；階段（庫保存階段、庫表徵和測試階段、庫準備階段）

受訪公司範例

• ATCC（American Type Culture Collection）
• BioOutsource Ltd.
• BioReliance Corporation
• BSL Bioservice
• CellBank Australia
• Charles River Laboratories, Inc.
• Clean Biologics
• Cordlife Group Limited
• Covance Inc.
• Cryo-Cell International Inc.
• Cryoviva India
• Eurofins Scientific
• GBI
• LifeCell International Pvt. Ltd
• Lonza Group Ltd.
• Merck KGaA
• Paragon Bioservices, Inc.
• Reliance Life Sciences
• Sartorius AG
• SGS Life Sciences

人工智慧整合

全球產業分析師正在利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global 特定產業產業SLM 的典型規範，而是建立了一個從世界各地專家收集的內容庫，包括影片錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地以及進出口情況（成品和原始OEM）預測其競爭地位的變化。這種複雜多變的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

• 市場概覽
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 競賽

Global Cell Banking Outsourcing Market to Reach US$34.0 Billion by 2030

The global market for Cell Banking Outsourcing estimated at US$13.9 Billion in the year 2024, is expected to reach US$34.0 Billion by 2030, growing at a CAGR of 16.1% over the analysis period 2024-2030. Master Cell Banking, one of the segments analyzed in the report, is expected to record a 18.5% CAGR and reach US$19.7 Billion by the end of the analysis period. Growth in the Working Cell Banking segment is estimated at 14.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.8 Billion While China is Forecast to Grow at 21.7% CAGR

The Cell Banking Outsourcing market in the U.S. is estimated at US$3.8 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$7.6 Billion by the year 2030 trailing a CAGR of 21.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.6% and 14.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.9% CAGR.

Global Cell Banking Outsourcing Market - Key Trends & Drivers Summarized

Why Is the Demand for Cell Banking Outsourcing Increasing?

The demand for cell banking outsourcing is increasing due to the rising adoption of cell-based therapies, regenerative medicine, and biopharmaceutical research. As pharmaceutical and biotechnology companies focus on the development of cell and gene therapies, personalized medicine, and vaccine production, the need for high-quality, well-preserved cell lines has grown significantly. Outsourcing cell banking services allows research institutions and drug developers to store, expand, and manage their cell lines without the burden of maintaining costly in-house infrastructure.

The increasing number of clinical trials for stem cell therapies, monoclonal antibodies, and biologics has further fueled the demand for cell banking outsourcing. The complexity of cell-based product development requires stringent quality control, compliance with Good Manufacturing Practices (GMP), and secure long-term storage, making outsourcing an attractive option for companies looking to optimize costs and ensure regulatory compliance. Additionally, as personalized medicine continues to evolve, there is a growing emphasis on ensuring the safety, traceability, and viability of cell lines, further driving the need for reliable and specialized cell banking services.

How Are Technological Advancements Improving Cell Banking Outsourcing?

Innovations in cryopreservation, automated bioprocessing, and quality assurance techniques are revolutionizing cell banking outsourcing, improving the efficiency and reliability of long-term cell storage. One of the most significant advancements is the development of advanced cryoprotectants and controlled-rate freezing technologies, which enhance the viability and stability of stored cells. These innovations reduce the risks of genetic drift and cell degradation, ensuring the long-term usability of biological samples for research and therapeutic applications.

Another major breakthrough is the integration of artificial intelligence and automation in cell banking operations. AI-driven predictive analytics and robotic handling systems are improving process consistency, reducing human error, and optimizing storage conditions. Additionally, blockchain technology is being explored for secure data management and traceability, ensuring full transparency and compliance in cell banking records. The adoption of cloud-based sample tracking and digital inventory management systems is further enhancing operational efficiency, allowing clients to remotely monitor and manage their stored cell lines in real time.

Which Market Trends Are Driving Growth in the Cell Banking Outsourcing Industry?

The increasing focus on regenerative medicine and cell therapy development is one of the most influential trends shaping the cell banking outsourcing market. With stem cell research gaining momentum for treating neurodegenerative disorders, cardiovascular diseases, and rare genetic conditions, demand for high-quality stem cell banking services is growing. Biopharmaceutical companies are also expanding their reliance on outsourced cell banking for large-scale production of biologics, including monoclonal antibodies and recombinant proteins.

Another key trend influencing market growth is the regulatory emphasis on Good Manufacturing Practices and standardized cell preservation protocols. As global regulatory agencies tighten guidelines on cell therapy manufacturing and storage, outsourcing providers are investing in higher biosafety levels, GMP-compliant facilities, and advanced monitoring systems to meet industry standards. Additionally, the rise of international collaborations in biotech research is driving demand for centralized cell banking services, allowing companies to access high-quality cell lines across multiple regions. With the rapid expansion of cell-based research and therapeutics, outsourcing cell banking has become a strategic necessity for many life sciences companies.

What Are the Key Growth Drivers Shaping the Future of the Cell Banking Outsourcing Market?

The growth in the cell banking outsourcing market is driven by several factors, including increasing demand for cell-based therapies, advancements in biopreservation technologies, and rising investments in biopharmaceutical research. One of the primary growth drivers is the expansion of clinical trials for cell and gene therapies, which require secure and well-maintained cell lines for development and regulatory approval. As pharmaceutical companies and research institutions accelerate their efforts in regenerative medicine, the need for reliable cell banking partners is becoming increasingly critical.

Another crucial driver shaping the market is the increasing adoption of personalized medicine and precision therapies. With cell-based treatments becoming more patient-specific, the demand for customized cell banking solutions, including autologous and allogeneic storage services, is on the rise. Additionally, partnerships between biopharmaceutical companies and contract development and manufacturing organizations (CDMOs) are expanding, allowing for more scalable and cost-effective outsourcing solutions. As the life sciences industry continues to innovate, cell banking outsourcing is expected to play a pivotal role in advancing therapeutic breakthroughs, ensuring long-term sample viability, and supporting the next generation of biopharmaceutical development.

SCOPE OF STUDY:

The report analyzes the Cell Banking Outsourcing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Master Cell Banking, Working Cell Banking, Viral Cell Banking); Cell Type (Stem Cells, Non-stem Cells); Phase (Bank Storage Phase, Bank Characterization and Testing Phase, Bank Preparation Phase)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

• ATCC (American Type Culture Collection)
• BioOutsource Ltd.
• BioReliance Corporation
• BSL Bioservice
• CellBank Australia
• Charles River Laboratories, Inc.
• Clean Biologics
• Cordlife Group Limited
• Covance Inc.
• Cryo-Cell International Inc.
• Cryoviva India
• Eurofins Scientific
• GBI
• LifeCell International Pvt. Ltd
• Lonza Group Ltd.
• Merck KGaA
• Paragon Bioservices, Inc.
• Reliance Life Sciences
• Sartorius AG
• SGS Life Sciences

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Cell Banking Outsourcing - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Demand for Biologics and Cell-Based Therapies Throws the Spotlight on Cell Banking Outsourcing Solutions
  • Rapid Growth in Cell and Gene Therapy Pipelines Propels the Need for High-Quality Master and Working Cell Banks
  • Increasing Complexity of GMP and Regulatory Compliance Strengthens the Business Case for Outsourced Cell Banking Providers
  • Expansion of Personalized Medicine and Autologous Therapies Drives Custom Cell Bank Storage Requirements
  • Biopharmaceutical Shift Toward Outsourcing Models Fuels Growth in Contract Cell Banking Services
  • Growing Adoption of cGMP-Compliant Facilities Enhances Demand for Specialized Cell Storage and Characterization Services
  • Globalization of Clinical Trials and Manufacturing Operations Expands the Addressable Market for Multi-Site Cell Banking
  • Rising Investment in Stem Cell Research and Regenerative Medicine Creates New Service Demand in Cell Banking Logistics
  • Increased Focus on Supply Chain Risk Mitigation Spurs Interest in Redundant and Disaster-Proof Cell Storage Models
  • Expansion of Allogeneic Cell Therapy Platforms Accelerates Demand for Scalable Banking Infrastructure
  • Stringent Quality Control, Authentication, and Contamination Prevention Standards Drive Laboratory Automation Adoption
  • Emergence of Biobanking-as-a-Service (BaaS) Models Creates Flexible Access for Smaller Biotech Firms
  • Integration of Digital Chain-of-Custody and Sample Tracking Technologies Enhances Service Transparency and Reliability
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Cell Banking Outsourcing Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Cell Banking Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Cell Banking Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Master Cell Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Master Cell Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Master Cell Banking by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Working Cell Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Working Cell Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Working Cell Banking by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Viral Cell Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Viral Cell Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Viral Cell Banking by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Non-stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Non-stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Non-stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Bank Storage Phase by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Bank Storage Phase by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Bank Storage Phase by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Bank Characterization & Testing Phase by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Bank Characterization & Testing Phase by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Bank Characterization & Testing Phase by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Bank Preparation Phase by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Bank Preparation Phase by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Bank Preparation Phase by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 29: USA Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 30: USA Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: USA 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
  • TABLE 32: USA Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: USA 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
  • TABLE 35: USA Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 38: Canada Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: Canada Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: Canada 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: Canada 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: Canada 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
• JAPAN
  • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 47: Japan Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Japan Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: Japan 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Japan 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Japan 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
• CHINA
  • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 56: China Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: China Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: China 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
  • TABLE 59: China Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: China 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
  • TABLE 62: China Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
• EUROPE
  • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 65: Europe Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 66: Europe Historic Review for Cell Banking Outsourcing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Europe 15-Year Perspective for Cell Banking Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Europe 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
• FRANCE
  • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 77: France Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: France Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: France 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
  • TABLE 80: France Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: France 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
  • TABLE 83: France Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: France 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
• GERMANY
  • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 86: Germany Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Germany Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Germany 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Germany 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Germany 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 95: Italy Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Italy Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Italy 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Italy 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Italy 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 104: UK Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: UK Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: UK 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
  • TABLE 107: UK Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: UK 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
  • TABLE 110: UK Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: UK 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 113: Spain Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Spain Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Spain 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Spain 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Spain 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 122: Russia Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Russia Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Russia 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Russia 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Russia 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Rest of Europe Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Rest of Europe 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 141: Asia-Pacific Historic Review for Cell Banking Outsourcing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Asia-Pacific 15-Year Perspective for Cell Banking Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 152: Australia Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Australia Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Australia 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Australia 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Australia 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
• INDIA
  • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 161: India Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: India Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: India 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
  • TABLE 164: India Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: India 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
  • TABLE 167: India Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: India 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 170: South Korea Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: South Korea Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: South Korea 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: South Korea 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: South Korea 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Asia-Pacific Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Rest of Asia-Pacific 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 188: Latin America Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 189: Latin America Historic Review for Cell Banking Outsourcing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Latin America 15-Year Perspective for Cell Banking Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Latin America 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Latin America 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 200: Argentina Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Argentina Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Argentina 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Argentina 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Argentina 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 209: Brazil Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Brazil Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Brazil 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Brazil 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Brazil 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 218: Mexico Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Mexico Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Mexico 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Mexico 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Mexico 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Rest of Latin America Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Rest of Latin America 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 236: Middle East Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 237: Middle East Historic Review for Cell Banking Outsourcing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Middle East 15-Year Perspective for Cell Banking Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Middle East 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Middle East 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 248: Iran Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Iran Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Iran 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Iran 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Iran 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 257: Israel Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Israel Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Israel 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Israel 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Israel 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Saudi Arabia Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Saudi Arabia 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 275: UAE Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: UAE Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: UAE 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: UAE 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: UAE 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Rest of Middle East Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Rest of Middle East 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030
• AFRICA
  • Cell Banking Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 293: Africa Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Africa Historic Review for Cell Banking Outsourcing by Type - Master Cell Banking, Working Cell Banking and Viral Cell Banking Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Africa 15-Year Perspective for Cell Banking Outsourcing by Type - Percentage Breakdown of Value Sales for Master Cell Banking, Working Cell Banking and Viral Cell Banking for the Years 2015, 2025 & 2030
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Cell Banking Outsourcing by Cell Type - Stem Cells and Non-stem Cells Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Africa 15-Year Perspective for Cell Banking Outsourcing by Cell Type - Percentage Breakdown of Value Sales for Stem Cells and Non-stem Cells for the Years 2015, 2025 & 2030
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Cell Banking Outsourcing by Phase - Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Africa 15-Year Perspective for Cell Banking Outsourcing by Phase - Percentage Breakdown of Value Sales for Bank Storage Phase, Bank Characterization & Testing Phase and Bank Preparation Phase for the Years 2015, 2025 & 2030

IV. COMPETITION